Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ventilation and Perfusion in Asthmatics
Sponsor: University of Miami
Summary
Assess regional changes to perfusion and ventilation from inhaled corticosteroid (ICS) and Fast-acting beta-antagonist (FABA) among adult asthmatics using radiographically derived estimates of regional ventilation (V-distribution), ventilation defect percentage (VDP), and ventilation heterogeneity (VH).
Official title: Ventilation and Perfusion in Individuals With Asthma
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-04
Completion Date
2028-04
Last Updated
2026-04-07
Healthy Volunteers
No
Conditions
Interventions
Albuterol Sulfate
Visit 1: Albuterol Sulfate (90mcg) two puffs will be administered via metered-dose inhaler (MDI) with spacer during the baseline study visit to obtain baseline imaging values.
Albuterol-Budesonide
Visit 2: AIRSUPRA (Albuterol/Budesonide) (90mcg/80mcg) two puffs will be administered via MDI with spacer during this study visit. This intervention is used to evaluate its effect on ventilation defect percentage (VDP), ventilation heterogeneity (VH), and perfusion metrics derived from XV LVAS imaging
Locations (1)
University of Miami - Converge Miami
Miami, Florida, United States